Shanghai General Healthy Information and Technology Co., Ltd.
XSSC:605186 Stock Report
Market Cap: CN¥2.9b
Shanghai General Healthy Information and Technology Valuation
Is 605186 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6
Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 605186 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 605186 (CN¥21.55) is trading above our estimate of fair value (CN¥2.09)
Significantly Below Fair Value: 605186 is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 605186?
Key metric: As 605186 is barely profitable we use its Price-To-Sales Ratio for relative valuation analysis.
The above table shows the Price to Sales ratio for 605186. This is calculated by dividing 605186's market cap by their current
revenue.
What is 605186's PS Ratio?
PS Ratio
11.2x
Sales
CN¥261.57m
Market Cap
CN¥2.93b
605186 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Sales vs Industry: 605186 is expensive based on its Price-To-Sales Ratio (11.2x) compared to the CN Medical Equipment industry average (6.4x).
Price to Sales Ratio vs Fair Ratio
What is 605186's PS Ratio
compared to its
Fair PS Ratio?
This is the expected PS Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
605186 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio
11.2x
Fair PS Ratio
5x
Price-To-Sales vs Fair Ratio: 605186 is expensive based on its Price-To-Sales Ratio (11.2x) compared to the estimated Fair Price-To-Sales Ratio (5x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.